Nuedexta
4 trials in this asset. Source: ClinicalTrials.gov, as of July 21, 2026.
Trials
4
Ongoing
0
Recruiting
0
Completed
3
Sites
84
Countries
1
Endpoints
71
Composite endpoints
0
Distinct sites and countries across this asset's trials. A site running several of its trials counts once, matching the map. All 71 linked ClinicalTrials.gov endpoints are classified into the categories below. Trial and endpoint linkage does not by itself establish treatment attribution for every endpoint.
Development
Where the program stands
Trials by phase
Trials by status
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Most-measured metrics
Top 20 metrics across this asset's endpoints
Normalized metric codes are available for 24 of 71 classified ClinicalTrials.gov endpoints for this asset; the ranking below covers that coded subset.
20
2
2
Trials
Trials for this asset
Every trial for this asset, with the same search, filters, and sort as the Trials tab.
4 of 4
| Asset / Disease area | Key I/E criterion | Evidence | ||||||
|---|---|---|---|---|---|---|---|---|
| NCT01584440Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Participants With Alzheimer's Disease | Nuedexta Alzheimer’s disease | Alzheimer's disease | Ph 2 | Completed | 44 | Jul 2014 | 1 | results |
| NCT00056524Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) | Nuedexta Alzheimer’s disease | Age 18-80 | Ph 3 | Completed | 39 | Jun 2007 | 1 | |
| NCT01832350Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease | Nuedexta Alzheimer’s disease | Alzheimer's disease | Ph 4 | Terminated | 1 | Dec 2015 | 8 | |
| PRISM IISafety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA) | Nuedexta Mixed / unspecified dementia | Age ≥18 | Ph 4 | Completed | 1 | May 2015 | 3 | results |
Showing 1-4 of 4 trials